Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Godse, Kiran; De, Abhishek; Zawar, Vijay; Shah, Bela; Girdhar, Mukesh; Rajagopalan, Murlidhar; Krupashankar, D S

Godse, Kiran; De, Abhishek; Zawar, Vijay; Shah, Bela; Girdhar, Mukesh; Rajagopalan, Murlidhar; Krupashankar, D S.

Afiliação

Godse K; Department of Dermatology, D Y Patil Hospital, Navi Mumbai, Maharastra, India.
De A; Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India.
Zawar V; Department of Dermatology, Skin Diseases Center, Nashik, India.
Shah B; Department of Dermatology, BJ Medical College, Ahmedabad, Gujarat, India.
Girdhar M; Department of Dermatology, Max Super Speciality Hospital, New Delhi, India.
Rajagopalan M; Department of Dermatology, Apollo Hospital, Chennai, Tamil Nadu, India.
Krupashankar DS; Department of Dermatology, Krupa Shankar Skin Care Center, Mallige Hospital, Bengaluru, Karnataka, India.

Indian J Dermatol ; 63(1): 2-15, 2018.

Article em En | MEDLINE | ID: mdl-29527019

Palavras-chave

Angioedema; Indian guidelines; antihistamine; autologous serum therapy; chronic urticaria; cyclosporine; hydroxyzine; methotrexate; montelukast; omalizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2018 Tipo de documento: Article